- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Patent holdings for IPC class A61K 47/26
Total number of patents in this class: 11118
10-year publication summary
|
808
|
833
|
968
|
1031
|
1204
|
1142
|
1113
|
1169
|
1136
|
968
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4873 |
102 |
| Amgen Inc. | 4483 |
82 |
| Azurity Pharmaceuticals, Inc. | 268 |
80 |
| Takeda Pharmaceutical Company Limited | 2709 |
77 |
| Genentech, Inc. | 4157 |
68 |
| Novartis AG | 10170 |
63 |
| Merck Sharp & Dohme LLC | 3734 |
53 |
| Hoffmann-La Roche Inc. | 3864 |
50 |
| Pfizer Inc. | 3423 |
50 |
| Janssen Biotech, Inc. | 1798 |
50 |
| Allergan, Inc. | 2145 |
49 |
| Chiesi Farmaceutici S.p.A. | 953 |
47 |
| Daiichi Sankyo Company, Limited | 1900 |
45 |
| Chugai Seiyaku Kabushiki Kaisha | 1435 |
42 |
| Alkermes Pharma Ireland Limited | 254 |
40 |
| Hanmi Pharm. Co., Ltd. | 605 |
39 |
| F. Hoffmann-La Roche AG | 7795 |
38 |
| Bristol-myers Squibb Company | 4747 |
35 |
| Astellas Pharma Inc. | 1041 |
35 |
| Arecor Limited | 105 |
32 |
| Other owners | 10041 |